Drug intelligence / Profile preview

untransduced NK cells

Development stage
Unknown
Lead developer
NKore BioTherapeutics
Modality
CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

Untransduced NK cells are **primary human natural killer (NK) cells** that have not been genetically modified or transduced with viral vectors or transgenes. NK cells are innate lymphoid cells recognized for their **ability to mediate cytotoxic activity against virus-infected and malignant cells without prior antigen sensitization**. They exert their effects via direct cytolysis using lytic granules (containing perforin and granzymes) as well as by producing cytokines such as IFN-γ and TNF-α. Unlike transduced NK cells (such as CAR NK cells), untransduced NK cells are typically used as negative controls in experimental immunotherapy development or as native cell therapy products. They are of interest in research and clinical trials for their **role in antitumor immunity and immunotherapy approaches** in the treatment of hematological malignancies and infections[1][2][3][4].

Other names
untransduced NK cells

Beyond the preview

Go deeper on untransduced NK cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on untransduced NK cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call